Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in ACADIA PHARMACEUTICALS INC
BNP PARIBAS FINANCIAL MARKETS holds 70,812 shares of ACAD (ACADIA PHARMACEUTICALS INC), worth $1.6M as of 2026-Q1. The position was increased (+58.2% shares). ACAD represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.
Current Value
$1.6M
Current Shares
70,812
Total Value Change
+$564,111
Total Shares Change
+8,525
Other major holders of ACAD: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 70,812 |
+58.2% |
| $1.6M |
| 0.0% |
| $22.50 |
37 |
| 2025-Q4 | Decreased | 44,756 | -19.4% | $1.2M | 0.0% | $26.70 | 0 |
| 2025-Q3 | Decreased | 55,548 | -27.6% | $1.2M | 0.0% | $21.32 | 0 |
| 2025-Q2 | Decreased | 76,754 | -67.7% | $1.7M | 0.0% | $22.12 | 0 |
| 2025-Q1 | Decreased | 237,410 | -17.7% | $3.9M | 0.0% | $17.07 | 0 |
| 2024-Q4 | Increased | 288,471 | +29.0% | $5.3M | 0.0% | $16.69 | 34 |
| 2024-Q3 | Increased | 223,618 | +259.0% | $3.4M | 0.0% | $15.69 | 43 |
| 2024-Q2 | Decreased | 62,287 | -48.2% | $1M | 0.0% | $16.25 | 0 |